Fibromuscular dysplasia (FMD)

David Goldemund M.D.
Updated on 26/01/2024, published on 14/03/2022

  • mostly sporadic, rarely hereditary, noninflammatory disease of unknown etiology affecting medium-sized arteries
  • localization (usually sparing the origin of the vessel):
    • an extracranial portion of the ICA/vertebral arteries
    • renal arteries (most common)
    • splanchnic arteries (rare)
    • subclavian, axillary, and iliac arteries (rare)
  • usually occurs in young to middle-aged women
    • F: M ratio of 3:1
    • onset typically between 30 and 50 years of age
  • involved arteries show segmental stenoses and enlargements, with approximately one-third of patients having multiple lesions
  • FMD can lead to serious complications (TIA/stroke, spontaneous dissection, aneurysm formation, myocardial infarction)


  • unknown etiology
    • identification of YY1AP1 mutations (typical for Grange syndrome) as a cause of FMD indicates that this condition may result from various genetic disorders (Guo, 2017)
  • fibrous or fibromuscular thickening of the arterial wall (intima, media, and adventitia) leading to segmental stenoses and microaneurysms
    • intima is involved in < 5% of cases (⇒ intimal fibroplasia, also called carotid web)
    • media involvement is predominant (90-95% of cases)
    • adventitia (rare, less than 1% of cases)
  • histology
    • accumulations of dysplastic muscle cells + disruption of the internal elastic membrane
    • no inflammatory cells are present
  • carotid lesions are typically localized in the middle and distal segments of the extracranial internal carotid artery, often extending to the skull base
  • FMD predisposes to the development of aneurysms (extra- and intracranial) and arterial dissections
    • ⇒ it is advisable to examine the renal arteries in all patients presenting with arterial dissection
Fibromuscular dysplasia (FMD)

Clinical presentation and diagnostic evaluation

  • carotid artery lesions are often asymptomatic but can cause TIA/stroke due to:
  • renal artery involvement leads to renovascular hypertension (by activating RAAS) or renal impairment
  • coronary artery involvement can lead to angina pectoris, myocardial infarction, and cardiac death
  • FMD is diagnosed by a typical appearance on vascular imaging (CTA, MRA, DSA, ultrasound)
    • affected arteries usually exhibit a rosary-like appearance caused by concentric luminal narrowing alternating with areas of mural dilatation (a string of beads/pearls appearance)   Fibromuscular dysplasia (FMD) - carotid artery in ultrasound imaging Fibromuscular dysplasia (FMD) - renal arteries on CTA
      • this finding is present in up to 90% of patients with FMD
    • less commonly, patients may present with concentric long-segment tubular stenosis
  • FMD may manifest as carotid dissection (best seen on fat-saturated T1 imaging)  ICA dissection with intramural hematoma (fat-saturated T1)
  • less typical features include intracranial aneurysms that can lead to subarachnoid hemorrhage (SAH)
Content available only for logged-in subscribers (registration will be available soon)
Fibromuscular dysplasia (FMD) - renal and carotid artery on DSA and CTA
Fibromuscular dysplasia (FMD) on CTA and US (B-flow mode)
Fibromuscular dysplasia (FMD) - carotid artery on CTA

Fibromuscular dysplasia (FMD) - carotid artery on CTA

Differential diagnosis

  • atherosclerosis – usually present at the origin or proximal segment of the ICA
  • vasculitis
    • ↑ ESR
    • extensive or diffuse thickening of the wall (Takayasu)  Takayasu arteritis on ultrasound
  • segmental arterial mediolysis (Chao, 2009)
    • noninflammatory arteriopathy characterized by dissecting aneurysms resulting from lysis of the outer media of the arterial wall
  • vasospasms


Acute stroke therapy

Stroke prevention

  • asymptomatic carotid lesions – a conservative approach is preferred; antiplatelet therapy is not recommended
  • stroke patients with FMD:
    • the strict control of blood pressure and other vascular risk factors
    • antiplatelet therapy  (AHA/ASA 2021 I/C-LD)
      • ASA is most commonly used (based on expert opinion, no trials available)
      • statins are not routinely used unless there is another indication
    • for stroke caused by carotid dissection without thrombosis, antiplatelet therapy is usually used (AHA/ASA 2021 2a/C-EO)
    • if medical treatment fails or significant carotid artery stenosis develops, consider angioplasty (AHA/ASA 2021 2b/C-LD)   (Tekieli, 2015)
      • angioplasty for FMD has high long-term patency rates; stenting is not always required
      • robust data on the clinical benefit of CAS over conservative therapy are lacking

Renovascular hypertension

  • renal artery angioplasty with stenting is indicated in proven renovascular hypertension if significant stenosis of the renal artery affects blood flow to the kidney
    • the RAA system provides adequate glomerular pressure by vasoconstriction; this compensatory mechanism can lead to hypertension
    • ACE inhibitors, commonly used to manage hypertension, can cause renal hypoperfusion
  • the decision to perform renal angioplasty should be made based on the individual patient’s condition, the severity of renal artery stenosis, and other factors

You cannot copy content of this page

Send this to a friend
you may find this topic useful:

Fibromuscular dysplasia (FMD)